PEOPLE ON THE MOVE

Veeva

29-Apr-2015 - Last updated on 30-Apr-2015 at 13:19 GMT

Kilian Weiss, former Qforma CEO, has become General Manager of KOL Solutions following Veeva’s acquisition of the business from Qforma.

Weiss will be responsible for Veeva’s new KOL (key opinion leader) data and services division.

Before joining Veeva, he founded Mederi AG, a KOL services company. He followed by becoming Chief Executive of Qforma, where he developed Qforma CrowdLink, a KOL product for life science companies.

Novo Nordisk

US Pharmacopeial Convention

Veeva

Sciformix

Related news

Related products

Why should you use clinical trial technology?

Content provided by Formedix | 16-Oct-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape.

ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

Recipharm AB | Recorded the 14-Sep-2023 | Webinar

Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity
Customizing the downstream process to...

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...